Navigation Links
Wyeth Applauds Six Countries Across Europe, and the Middle East, That Recently Announced the Inclusion of the 7-Valent Pneumococcal Conjugate Vaccine (PCV7) in Their Immunization Schedules
Date:7/8/2008

MAIDENHEAD, England, July 8 /PRNewswire-FirstCall/ --

- PREVENAR Vaccine to Help Protect Children Against the Leading Vaccine-Preventable Cause of Death in Young Children

Wyeth applauds the countries of Cyprus, Hungary, the Kingdom of Bahrain, Republic of Ireland, Slovak Republic and Sweden for announcing their decisions to routinely immunize infants and young children against pneumococcal disease by adding PREVENAR(TM) PCV7 (Pneumococcal Saccharide Conjugated Vaccine, Adsorbed) to their national immunization programs(1). This announcement makes it 24 countries across the world that have now included Prevenar in their immunizations schedules(1).

"We share these countries' commitment to protecting children from the potentially devastating effects of pneumococcal disease and applaud the swift action they have taken in addressing this urgent and pressing health issue," says Bernard Fritzell, Vice President, International Scientific & Clinical Affairs, Wyeth Vaccines Research, in Paris, France. "Wyeth is dedicated to the wellbeing of children and to working with other governments and agencies to further expand the access to Prevenar. This includes accelerating the introduction of the vaccine in those countries that have announced their decision to incorporate Prevenar in their National Immunisation Programmes but have yet to introduce the vaccine as part of their immunization schedule."

This is important news as pneumococcal disease results in 1.6 million deaths per year worldwide, of which up to 1 million deaths are in children younger than five years of age(2). Pneumococcal disease is the leading vaccine-preventable cause of death in children younger than five years of age worldwide(3).

"Specifically, since the introduction of PCV7, into Germany's paediatric immunization schedule in 2006, there has been a 50 percent reduction in vaccine-type invasive pneumococcal disease (IPD) in children younger than 2 years old compared with
'/>"/>

SOURCE Wyeth Pharmaceuticals
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Trubion Pharmaceuticals Announces Extension of Research Period Under Its Wyeth Collaboration
2. Wyeth Initiates INTORACT -- A New Clinical Trial to Examine TORISEL Plus Avastin for First-Line Treatment of Advanced Kidney Cancer
3. Wyeth Receives Approvable Letter from FDA for TYGACIL for the Treatment of Patients with Community-Acquired Pneumonia
4. Wyeth Receives FDA Fast Track Designation for its 13-valent Pneumococcal Conjugate Vaccine for Infants and Toddlers
5. Wyeth Receives Approvable Letter From FDA for Bazedoxifene for the Treatment of Postmenopausal Osteoporosis
6. Wyeth and Progenics Announce Preliminary Clinical Trial Results for RELISTOR Oral and Intravenous Formulations
7. Arthritis Foundation Announces Amgen and Wyeth to Be Presenting Sponsor of the 2008 Arthritis Walk (R)
8. Wyeths TORISEL Receives European Commission Approval for the Treatment of Advanced Kidney Cancer
9. FDA Accepts Wyeths Supplemental New Drug Application for Tygacil for the Treatment of Patients with Community-Acquired Pneumonia
10. Wyeth Presents New Phase 3 Data and Updates Regulatory Timing for NDA Filing of Bazedoxifene/Conjugated Estrogens
11. Wyeth Presents Phase 3 Fracture Data for Bazedoxifene, an Investigational Therapy for Osteoporosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... -- BioSpecifics Technologies Corp. (NASDAQ: BSTC ), a biopharmaceutical ... ® in the U.S. and XIAPEX ® in ... , will present at the following upcoming investor conferences. ... & Renshaw 16 th Annual Global Investment Conference ( ... 2014 at 9:10 a.m. EDT , Aegis Capital ...
(Date:9/2/2014)... AVIV, Israel , September 2, 2014 ... "Company") (TASE, NASDAQ: EMITF ) announced today ... Elbit Medical Technologies Ltd. ("Elbit Medical") (TASE: EMTC-M), a ... 85% on a fully diluted basis, announced that on ... Medical holds approximately 30.8% of the voting power ("Gamida ...
(Date:9/2/2014)... N.J. , Sept. 2, 2014 /PRNewswire/ ... Company), a clinical stage biopharmaceutical company focused ... diseases where there remains an unmet medical ... vaccines and therapeutics, announced today promising preliminary ... ricin toxin vaccine RiVax™, in a non-human ...
Breaking Medicine Technology:BioSpecifics Technologies Corp. Announces Presentations at Upcoming Investor Conferences 2Elbit Imaging Announces Gamida Cell Closed Option and Investment Agreements with a Major Pharmaceutical Company 2Elbit Imaging Announces Gamida Cell Closed Option and Investment Agreements with a Major Pharmaceutical Company 3Soligenix Announces Positive Survival Results with Heat Stable Ricin Toxin Vaccine 2Soligenix Announces Positive Survival Results with Heat Stable Ricin Toxin Vaccine 3Soligenix Announces Positive Survival Results with Heat Stable Ricin Toxin Vaccine 4Soligenix Announces Positive Survival Results with Heat Stable Ricin Toxin Vaccine 5Soligenix Announces Positive Survival Results with Heat Stable Ricin Toxin Vaccine 6Soligenix Announces Positive Survival Results with Heat Stable Ricin Toxin Vaccine 7Soligenix Announces Positive Survival Results with Heat Stable Ricin Toxin Vaccine 8
... NEW YORK, Jan. 13, 2011 Although 2010 brought ... healthcare reform repeal.  Investors should likely expect some volatility ... wreak havoc on healthcare reform, either through a repeal ... according to analysts at Standard & Poor,s Equity Research. ...
... N.J., Jan. 13, 2011 Quest Diagnostics Incorporated (NYSE: ... information and services, announced today that it will report fourth ... for 2011 on Tuesday, January 25, before the market opens. ... discuss the results beginning at 8:30 a.m. ET on that ...
Cached Medicine Technology:S&P Equity Research Issues Health Care Sector Predictions for 2011 2S&P Equity Research Issues Health Care Sector Predictions for 2011 3S&P Equity Research Issues Health Care Sector Predictions for 2011 4S&P Equity Research Issues Health Care Sector Predictions for 2011 5S&P Equity Research Issues Health Care Sector Predictions for 2011 6Quest Diagnostics to Release Fourth Quarter and Full Year 2010 Financial Results 2
(Date:9/2/2014)... MyRounding, the leader in creating digital health solutions ... group of over 100 applicants to pitch in the ... The competition will pin Colorado’s top 10 digital health ... CSU Denver Atrium from 1 – 6 p.m. , ... The cloud-based, SaaS (Software as a Service), mobile platform ...
(Date:9/2/2014)... Jupiter, FL (PRWEB) September 02, 2014 ... today that they are gathering content for upcoming ... slated to air first quarter 2015. , Innovations, ... defining and exploring today's latest breakthroughs and advancements ... particular series will focus on advancements in biosciences. ...
(Date:9/2/2014)... September 02, 2014 With thoughts of ... on the minds of many Washingtonians, it’s easy to ... planners and office managers to be booking their organizations’ ... & Resorts' Washington, DC, area locations are preparing for ... dates available for holiday parties, the space appears to ...
(Date:9/2/2014)... On August 22 and 23, EarQ members from ... and Precious Hearing Inc. in Monroe, MI joined members ... National Basketball Retired Players Association (NBRPA) Legends World Sports ... former players and their families and discussing the importance ... screenings, video ear inspections, and discussed the benefits of ...
(Date:9/2/2014)... Michigan’s health care landscape has evolved with ... Healthy Michigan Plan. Throughout these changes, the Southwest Michigan ... resource for under-served individuals. Federal and state-funded programs will ... between the ages of 50 and 64 who have ... federal poverty level. , While this represents ...
Breaking Medicine News(10 mins):Health News:MyRounding Selected for Digital Health Venture Showcase Finals Top Three Startups Awarded $50,000 2Health News:Exciting New Episodes of Innovations with Ed Begley Jr to Air via Discovery Channel 2Health News:Fall in Washington, DC, Is When a Meeting Planner’s Mind Turns to … the Winter Holidays? 2Health News:Fall in Washington, DC, Is When a Meeting Planner’s Mind Turns to … the Winter Holidays? 3Health News:Fall in Washington, DC, Is When a Meeting Planner’s Mind Turns to … the Winter Holidays? 4Health News:Fall in Washington, DC, Is When a Meeting Planner’s Mind Turns to … the Winter Holidays? 5Health News:The EarQ Team Brings Hearing Health Awareness to the 2014 National Basketball Retired Players Association Annual Convention in Cancun 2Health News:Local Affiliate of National Health Organization Continues 16-Year Tradition of Funding Programs to Help Fill Gaps in Breast Health Services for Under-Served Populations 2Health News:Local Affiliate of National Health Organization Continues 16-Year Tradition of Funding Programs to Help Fill Gaps in Breast Health Services for Under-Served Populations 3
... are becoming common everywhere. Only last fortnight it was reported ... 15 ft during a joyride and sustained grievous injuries in ... ,But for a tree branch which checked her ... first aid facilities available, it was reported. ,Now ...
... with Delmont Laboratory to introduce its immunotherapeutic vaccine Staphage ... to this initial agreement, Delmont Laboratory will supply bulk ... the final packaging in China. ,CBPC will ... to be signed. This product requires a clinical study ...
... fill their prescriptions while traveling abroad need to be cautious ... the AAPS National Biotechnology Conference. ,Unlike approved ... internationally. Therefore, consumers should not assume that a branded product ... the same or similar brand name in other counties. ...
... seven billion dollar (5.2 billion euro) negligence suit against ... as the US giant demanded the charges be ... early setback when the court rejected a request to ... Babs Kwewumi adjourned the trial to July 20. ...
... announces that it has completed its acquisition of ... for approximately $600 million on April 4, 2007. ... owns the patents for Electrochemiluminescence (ECL) technology and ... diagnostics field into new market segments such as ...
... called the world's first prototype of an artificial hand with ... up a raw egg. ,Squse, a Kyoto-based ... 400-gramme (14 ounce) hand with five human-sized fingers with artificial ... ,"So far, robots have an image of helping people do ...
Cached Medicine News:Health News:Girls Feet Severed in Amusement Park Accident 2Health News:Nigeria Launches Seven Billion Dollar Case Against Pfizer 2Health News:Nigeria Launches Seven Billion Dollar Case Against Pfizer 3
... SINON is a Q-switched ... wavelength of 694 nm. High ... Pulses - This combination of ... pulses in Q-switched mode effectively ...
... an in vitro immunoassay intended for the qualititive ... antigen. It is indicated for use as an ... conjunction with cystoscopy or when prescribed for in ... FDA for prescription home use in February 1999. ...
... connect an infusion bag ... and then to a ... to conduct urodynamics studies. ... Medical Technologies infusion pumps. ...
... Used for cystometry and urethral ... allows for faster filling of the ... readings. Dual lumen catheter construction allows ... cystometry is performed. Triple lumen catheter ...
Medicine Products: